Tag Archives: Bristol-Myers Squibb

Anorexia and Cachexia – Causes, Symptoms, Diagnosis, Prognosis and Latest Treatment

Anorexia in Cancer Cancer anorexia-cachexia syndrome (CACS) is an extremely common condition in cancer patients.  It is estimated that 50% of cancer patients suffered from anorexia.  The exact frequency of CACS varies according to the primary pathology (from 30% in … Continue reading

Posted in Cancer, Gastric Cancer, Others, Pancreatic Cancer | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | 2 Comments

FDA Approves Halaven for Late-Stage Breast Cancer

Good news for patients with late stage metastatic breast cancer.  The US Food and Drug Administration (FDA) approved eribulin mesylate injection (Halaven; Eisai, Inc) for the treatment of metastatic breast cancer in patients who have received at least 2 prior … Continue reading

Posted in Breast cancer, Cancer | Tagged , , , , , , , , , , , , , , , | Comments Off on FDA Approves Halaven for Late-Stage Breast Cancer